Skip to main content
Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
21.69
+1.42 (7.01%)
At close: Dec 5, 2025, 4:00 PM EST
21.90
+0.21 (0.97%)
After-hours: Dec 5, 2025, 7:59 PM EST

Keros Therapeutics Employees

Keros Therapeutics had 169 employees as of December 31, 2024. The number of employees increased by 33 or 24.26% compared to the previous year.

Employees
169
Change (1Y)
33
Growth (1Y)
24.26%
Revenue / Employee
$1,459,870
Profits / Employee
$381,355
Market Cap
423.30M

Employees Chart

Employees History

Date Employees Change Growth
Dec 31, 20241693324.26%
Dec 31, 20231363129.52%
Dec 31, 20221054575.00%
Dec 31, 2021602571.43%
Dec 31, 2020351252.17%
Dec 31, 2019 Pro Pro Pro

Related Stocks

Company Name Employees
UnitedHealth Group 400,000
Johnson & Johnson 138,100
Thermo Fisher Scientific 125,000
Abbott Laboratories 114,000
AstraZeneca 92,900
Novo Nordisk 77,349
Novartis AG 75,883
Merck & Co. 75,000
Employee Rankings

KROS News

More News